Related Experiment Video
Updated: Mar 29, 2026
05:21
Establishment of A Mouse Model of Aqueous Deficiency Dry Eye
Published on: November 1, 2024
1.5K
Current and Developing Therapeutics for Dry Eye Disease: Targeting Ion Channels.
Rebecca Jung1, Emily Kao1, Victor H Guaiquil1
1Illinois Eye and Ear Infirmary, Department of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Current Issues in Molecular Biology
|March 28, 2026
Summary
Dry eye disease involves complex pain signaling. Targeting specific ion channels offers new hope for treating neuropathic ocular pain unresponsive to conventional therapies.
Area of Science:
- Ocular surface disease
- Neuroscience
- Pain signaling
Background:
- Dry eye disease (DED) is a complex ocular surface disorder with inflammation and neurosensory abnormalities.
- Conventional DED therapies often fail to address neuropathic ocular pain.
- Ion channels are crucial for ocular surface homeostasis, pain, and inflammation.
Purpose of the Study:
- To review the role of major ion channel families in DED pathophysiology and neuropathic ocular pain.
- To explore current and emerging therapies targeting ion channels for DED treatment.
Main Methods:
- Review of scientific literature on ion channels (TRP, Nav, P2X) in DED.
- Analysis of ion channel function, distribution, and response to stimuli.
- Evaluation of current DED treatments and their impact on ion channels.
- Introduction of novel therapies targeting sensory transduction pathways.
Main Results:
- Ion channels like TRP, Nav, and P2X receptors play significant roles in DED and neuropathic ocular pain.
- Understanding ion channel function provides insights into DED pathogenesis.
- Emerging therapies targeting ion channels show promise for personalized DED treatment.
Conclusions:
- Ion channel modulation presents a promising therapeutic strategy for DED, especially for neuropathic pain.
- Targeting sensory transduction pathways can personalize DED treatment for refractory cases.
- Further research into ion channel function can lead to innovative DED therapies.
Related Concept Videos
01:23Ophthalmic Drug Delivery Systems
212
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
212
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:28Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
2.0K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
2.0K
01:22Drug Delivery: Miscellaneous Routes
970
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
970
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.7K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.7K